Skip to main content
. 2023 Jun 26;11:1195657. doi: 10.3389/fpubh.2023.1195657

Table 2.

Overdose characteristics of young adult opioid users in New York City, 2014–16, among those with lifetime experience of overdose (N = 234).

Sample prevalence
Number (percent)
Population estimate
Percent (standard error)
Lifetime overdose among total sample (n = 539) 234 (43.4%) 46.6% (±14.6)
Age at first overdose
Mean (standard deviation)
20.4 (3.4)
Number of overdoses (n = 233, 1 participant missing data)
1 96 (41.2%) 38.9% (±11.8)
2–3 76 (32.6%) 39.6% (±11.5)
4 or more 61 (26.2%) 21.5% (±9.1)
Number of substances used at last overdose (n = 233, 1 participant missing data)
1 85 (36.5%) 41.1% (±11.4)
2 85 (36.5%) 37.3% (±11.4)
3 or more 63 (27.0%) 21.6% (±10.5)
Opioid(s) used at last overdose (n = 234)
Heroin only 162 (69.2%) 75.8% (±9.6)
PO only 28 (12.0%) 10.7% (±8.3)
Heroin and PO 19 (8.1%) 5.8% (±4.5)
No opioida 25 (10.7%) 7.6% (±3.4)
Route of heroin administration at last overdose (among the 181 who used heroin at last overdose, n = 178, 3 pts. missing data)
Injected 149 (83.7%) 80.8% (±11.8)
Snorted/sniffed 29 (16.3%) 19.2% (±11.8)
Smoked 0 (0%) 0% (±0)
Route of PO administration at last overdose b
Injected 5 (17.2%) 7.4% (±9.0)
Snorted/sniffed 5 (17.2%) 11.7% (±18.5)
Smoked 1 (3.5%) 9.1% (±29.6)
Oral 21 (72.4%) 75.8% (±29.8)

PO, prescription opioid.

a

Per the study’s operational definition of “overdose,” events that involved only non-opioid substances (e.g., alcohol, benzodiazepines, stimulants, etc.) were included, if they involved loss of consciousness and/or respiration or the person was unresponsive.

b

Percentages and population estimates total >100 because participants were able to report multiple routes.